Cellectar Biosciences, Inc.

Welcome

BiotechProfiles™ is the premier resource for jobs, company information, professional networking and productivity tools in the Madison, Wisconsin biotechnology and medical device industry. Recognized as one of the premier emerging biotechnology clusters in the U.S., this robust industry sector comprises nearly 10,000 employees in approximately 150 companies. BiotechProfiles also maintains a unique directory of the largest 250 pharmaceutical companies worldwide, including business development contacts whenever available. This tool is indispensable for executives pursuing strategic alliances and technology licenses.
Designed as a suite of easy to use, searchable databases that are continually updated, BiotechProfiles serves the needs of biotech business development and operational executives in early stage companies, as well as the general public. With these tools you can quickly bypass the data collection and screening stage and immediately focus on solving your strategic partnering or operational needs. We've assembled your background data for you!
  Next »

BiotechProfiles is also the premier site for data on Biotechnology Companies in Madison Wisconsin, Biotechnology Jobs in Madison Wisconsin

Biotechnology Companies in Madison Wisconsin; Biotechnology Jobs in Madison Wisconsin
  « Previous | Next »

Biotechnology Business Development, Partnering and Strategic Alliances

Biotechnology Business Development, Partnering and Strategic Alliances
  « Previous | Next »

Madison Biotechnology Companies; Madison Biotechnology Jobs

Madison Biotechnology Companies; Madison Biotechnology Jobs
  « Previous | Next »

List or rank of Largest Pharmaceutical Companies Worldwide

List of rank of Largest Pharmaceutical Companies Worldwide
  « Previous

Advertisement

Company Profile

Cellectar Biosciences, Inc. is a radiopharmaceuctial company dedicated to the development of small-molecule based radiotherapy treatments to treat a wide variety of human cancers with minimal side effects. Cellectar's novel product candidates combine lipid-like molecules, phospholipid ethers (PLEs), with radioisotopes that destroy malignant cells. Cellectar's products unique mechanism of action is based on their selective accumulation and retention in malignant tumors and not normal cells.
Business Sectors
Pharmaceuticals Human Diagnostics
Med or Lab Devices   Lab Reagents or Services  
Drug Manufacturing   Food & Agribusiness  
CRO   Bioinformatics or Software  
    Other  
Company History
Cellectar LLC was founded in 2002, and changed its name to Cellectar Inc in 2008. In April 2011, the company merged with publicly traded Novelos Therapeutics, Inc. The combined company has its operations and headquarters in Madison. In February 2014, the company changed its name to Cellectar Biosciences, Inc.
Cellectar Biosciences, Inc.
Address 3301 Agriculture Drive
[Map] Madison
WI
53716
Phone 608-441-8120
Fax 608-441-8121
Website Link
Head James Caruso
Company Statistics
Global Headcount 25
Local Headcount 25
Year Founded 2002
Ownership Public
Stock Exchange NASDAQ

Parent Company
Divisional Level
Senior Level
Global Headcount
Website
Stock Exchange
Reference Documents
News/Profiles
2016 - Founder Weichert Resigns [View]
2012 - Novelos Product Overview [View]
2007 - Cellectar Attacks Cancer from the Inside [View]
2008 - Cellectar Raises $13 million for Clinical Trials [View]
Selected Press Releases
2011 - Novelos Acquires Cellectar April 2011 [View]